Trial Profile

A multicentric, randomized, double-blind, placebo-controlled proof-of-concept study conducted in the United States to evaluate efficacy of estetrol in postmenopausal women with Female Sexual Arousal Disorder

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 07 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Feb 2024 According Mithra Pharmaceuticals media release, for this study the first patient screened at the end of January 2024. Recruitment is ongoing, and top-line results are anticipated by Q2 2025.
20 Jan 2022 New trial record
14 Jan 2022 According Mithra Pharmaceuticals media release, to this study will be launched in 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com